From Medscape Neurology

Coverage from the

American Epilepsy Society (AES) 2016 Annual Meeting

December 02 - 06, 2016; Houston, Texas

December 02 - 06, 2016 Houston, Texas

Conference News

Popular AES 2015 News

  • Cannabidiol Effective and Safe at 3 Months for Epilepsy Cannabidiol Effective and Safe at 3 Months for Epilepsy New open-label data on purified cannabidiol in children and young adults with treatment-resistant epilepsy are 'promising' at 3 months' follow-up, researchers say.
  • Ketamine for Refractory Status Epilepticus? Ketamine for Refractory Status Epilepticus? Ketamine, used for analgesia and sedation, is increasingly being used to treat refractory status epilepticus, but only for the most critically ill children, a new study suggests.
  • Autoimmune Epilepsy Gaining Attention Autoimmune Epilepsy Gaining Attention Researchers are learning more about antibodies that attack the brain, causing various seizure syndromes.

Medscape Neurology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource